
Truveta
Saving lives with data by providing regulatory-grade safety and effectiveness data.

Personalized genetic insights for health optimization and ancestry discovery.

23andMe is a leading personal genomics platform that utilizes high-throughput genotyping technology to decode individual genetic data. By 2026, the company has transitioned from simple ancestry reporting to a sophisticated 'Health-as-a-Service' model, leveraging Polygenic Risk Scores (PRS) and Machine Learning to predict chronic disease predispositions. Their technical architecture revolves around the Illumina Infinium Global Screening Array (GSA), which analyzes hundreds of thousands of variants (SNPs) across the genome. Beyond consumer reports, 23andMe maintains one of the world's largest opt-in genetic databases, facilitating large-scale pharmaceutical research and drug discovery via its internal research pipelines. The platform's 2026 market position is defined by its FDA-cleared health risk reports and its 'Total Health' tier, which incorporates clinical-grade Whole Exome Sequencing (WES) and bi-annual blood testing. This allows users to integrate their static genetic blueprint with dynamic longitudinal biomarkers, providing a holistic view of health. Despite historical data security challenges, the platform has implemented advanced encryption and decentralized data protocols to maintain its status as the primary consumer-facing genetics interface for preventive medicine.
23andMe is a leading personal genomics platform that utilizes high-throughput genotyping technology to decode individual genetic data.
Explore all tools that specialize in pharmacogenetics screening. This domain focus ensures 23andMe delivers optimized results for this specific requirement.
Uses machine learning models to aggregate the effects of thousands of genetic variants into a single score for conditions like Type 2 Diabetes and Hypertension.
Utilizes a smoothing algorithm and a reference panel of over 15,000 individuals to assign DNA segments to 2,000+ geographic regions.
Analyzes specific variants in the CYP2C19, DPYD, and SLCO1B1 genes to predict drug metabolic response.
Traces maternal and paternal lineages back to common ancestors using mitochondrial DNA and Y-chromosome analysis.
Compares user genotypes against known Neanderthal markers to calculate percentage of archaic DNA variants.
Visualizes exactly which segments of chromosomes are shared between matches to deduce shared ancestors.
Heuristic algorithms calculate likely genealogical relationships based on centimorgan (cM) sharing and age data.
Purchase a DNA collection kit through the official portal or authorized retailer.
Register the unique kit barcode via the mobile app or web interface to link your account.
Provide a saliva sample following the 30-minute fasting instructions.
Seal the sample in the provided biohazard bag and return via pre-paid shipping.
Sample undergoes DNA extraction at a CLIA-certified and CAP-accredited laboratory.
Genotyping is performed on a proprietary Illumina array to identify SNPs.
Bioinformatics pipelines process raw data against reference populations.
Quality control checks verify call rates and data integrity.
Final reports are generated and released to the user dashboard.
Users opt-in to specific health or research modules for ongoing insights.
All Set
Ready to go
Verified feedback from other users.
"Users praise the intuitive report design and extensive database for family matching, though many express concerns over data privacy and the shift toward subscription models."
Post questions, share tips, and help other users.

Saving lives with data by providing regulatory-grade safety and effectiveness data.

Breast AI trusted for better workflow and higher confidence in mammography screening.

Assistive communication solutions for people with disabilities.

Turn your diabetes data points into accessible, actionable, and meaningful insights.

Science-backed supplements for personalized wellness.

Hear everything in a heartbeat with advanced digital stethoscope technology.